Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
SucralfateF1 I SEP / 98
Sucroferric oxyhydroxidePDL I MAY / 18
SufentanilN I JUN / 02
Sulconazole and its saltsF1 I SEP / 98
Sulfinpyrazone and its saltsF1 I SEP / 98
Sulindac and its saltsF1 I SEP / 98
Sulphonamides or their salts or derivativesPDL

Including but not limited to Brinzolamide, succinylsulfathiazole, sulfacetamide, sulfadiazine, sulfadimethoxine, sulfadoxine, sulfaguanidine, sulfamerazine, sulfamethazine, sulfamethoxazole, sulfanilamide, sulfapyridine, sulfaquinoxaline, sulfasalazine, sulfathiazole, sulfisoxazole, sulphanilamide

I DEC / 18
Sulphones and their derivativesF1 I SEP / 98
Sumatriptan and its saltsF1 I SEP / 98
Sunitinib and its saltsF1 I OCT / 07
Suprofen and its saltsF1 I SEP / 98
Sutilains II SEP / 98
SuvorexantPDL I DEC / 18
Suxamethonium chlorideF1 I SEP / 98
Synthetic cannabinoid receptor type-1 agonists, their salts, derivatives, isomers, and salts of derivatives and isomersN

as listed in the schedules to the Controlled Drugs and Substances Act and the Narcotic Control Regulations

I JUL / 15
Tacrolimus and its derivativesF1 I SEP / 98
TalbutalC2 I JUN / 02
Taliglucerase alfaPDL I JUL / 14
Tamoxifen and its saltsF1 I SEP / 98
Tamsulosin and its saltsF1 I SEP / 99
TapentadolN (3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]-phenol), its salts, derivatives and isomers and salts of derivatives and isomers I JAN / 16
TazaroteneF1 I SEP / 98
Tazobactam and its salts and derivativesF1 I SEP / 98
Tedizolid or its salts or derivativesPDL

including but not limited to Tedizolid phosphate

I MAY / 15
TeduglutidePDL I OCT / 15
Tegafur and its saltsF1 I JUL / 03
Tegaserod and its saltsF1 I MAY / 04
Telaprevir or its derivativesPDL I DEC / 13
TelbivudineF1 I MAY / 09
Telmisartan and its salts and derivativesF1 I MAR / 01
Telotristat or its salts or derivativesPDL I NOV / 18
Temazepam and its saltsTS I SEP / 98
Temozolomide and its saltsF1 I MAR / 01
TeniposideF1 I SEP / 98
Tenofovir or its salts or derivativesPDL

Including but not limited to: tenofovir disoproxil, tenofovir alafenamide

I DEC / 13
Tenoxicam and its saltsF1 I SEP / 98
Terazosin and its saltsF1 I SEP / 98
Terbinafine and its saltsF1 I SEP / 98
Terbutaline and its saltsF1 I SEP / 98
Terconazole and its saltsF1 I SEP / 98
Terfenadine and its saltsF1 I SEP / 98
Teriparatide and its saltsF1 I APR / 07
Terlipressin and its saltsF1 I SEP / 98
Tesamorelin or its salts or derivativesPDL I MAY / 14
TestosteroneC3 I JUN / 02
Tetanus immune globulin I FEB / 02
Tetanus toxoid II DEC / 98
Tetrabenazine and its saltsF1 I SEP / 98
TetracainePDL

when in a preparation containing an equal amount of lidocaine and recommended for topical use on the skin, in concentrations of 7% or higher

I FEB / 14
Tetracaine and its salts

for ophthalmic or parenteral use

II SEP / 98
Tetracaine and its salts for topical use on mucous membranes, except lozenges III SEP / 98
Tetracycline or its salts or derivativesPDL I DEC / 18
Tetrahydrozoline in nasal preparations for pediatric use II SEP / 98
Tetrahydrozoline. for ophthalmic use and in nasal preparations for adults U
TetrazepamTS I JUN / 02
Tezacaftor or its saltsPDL I JUL / 18
ThalidomideF1 I SEP / 98
ThebaconN I JUN / 02
Thebaine (paramorphine)N I JUN / 02
Theophylline and its saltsF1 I SEP / 98
ThiabendazoleF2 I SEP / 98
ThialbarbitalC2 I JUN / 02
ThiamylalC2 I JUN / 02
Thiethylperazine and its saltsF1 I SEP / 98
Thiobarbituric AcidC2 I JUN / 02
ThiocarlideF1 I SEP / 98
ThiofentanylN I JUN / 02
ThioguanineF1 I SEP / 98
ThiopentalC2 I JUN / 02
Thiopropazate and its saltsF1 I SEP / 98
Thioproperazine and its saltsF1 I SEP / 98
Thioridazine and its saltsF1 I SEP / 98
ThiotepaF1 I SEP / 98
Thiothixene and its saltsF1 I SEP / 98
Thiouracil and its derivativesF1 I SEP / 98
Thrombin II SEP / 98
Thyroglobulin II SEP / 98
ThyroidF2 I SEP / 98
Thyrotropin II SEP / 98
Thyrotropin alfaF1 I MAY / 04
Thyroxin and its saltsF1 I SEP / 98
Tiamulin or its saltsPDL

For veterinary use, including but not limited to: Tiamulin fumarate

I DEC / 18
Tiaprofenic acid and its saltsF1 I SEP / 98
TiboloneC3 I JUN / 02
Ticagrelor or its derivativesPDL I DEC / 13
Ticlopidine and its saltsF1 I SEP / 98
TigecyclineF1 I APR / 08
Tilidine and its salts, derivatives and salts of derivativesN I JUN / 02
Tiludronic acid and its saltsF1 I SEP / 98
Timolol and its saltsF1 I SEP / 98
TinidazoleF1 I SEP / 98
Tinzaparin and its saltsF1 I SEP / 98
Tioconazole and its saltsF1

except in preparations for topical or vaginal use in humans

I SEP / 98
Tioconazole and its salts.F2 I SEP / 98
Tioconazole and its salts.. in preparations for intra-vaginal use III OCT / 98
Tioconazole and its salts... in preparations for topical use U OCT / 98
TiomesteroneC3 I JUN / 02
Tiotropium bromideF1 I MAY / 04
Tipiracil or its saltsPDL I MAR / 18
Tipranavir and its saltsF1 I FEB / 07

1948 result(s)


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drugs Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled